C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2002
11/26/2002	US6485797 5-Arylindane derivatives and ferroelectric liquid crystal mixture containing same
11/26/2002	CA2093203C Pyrimidine derivatives and processes for the preparation thereof
11/22/2002	WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002	CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002	WO2002092579A1 4-anilinoquinazoline derivatives
11/21/2002	WO2002092578A1 Quinazoline derivatives
11/21/2002	WO2002092577A1 Quinazoline derivatives
11/21/2002	WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	WO2002092556A1 Sulfonamide derivatives
11/21/2002	WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
11/21/2002	WO2002028841B1 Reagents for labeling biomolecules having aldehyde or ketone moieties
11/21/2002	US20020173665 Use treating pain, urinary incontinence and bladder overactivity
11/21/2002	US20020173649 Chloropvrimidine intermediates
11/21/2002	US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002	US20020173529 Fungicide active substance combinations
11/21/2002	US20020173515 Antiproliferative agents
11/21/2002	US20020173509 Quinazoline derivatives and phamaceutical compositions containing them
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173482 Antitumor, anticancer agents
11/21/2002	US20020173425 Herbicides
11/21/2002	DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002	CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	CA2443721A1 Sulfonamide derivatives
11/20/2002	EP1258250A1 Nerve protective drugs
11/20/2002	EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002	EP1257550A1 Platelet adp receptor inhibitors
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257540A1 Method for the production of 1-amino-3-aryl-uracils
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1042301B1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
11/20/2002	EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002	EP0837853B1 Substituted cyanophenyl uracils
11/20/2002	EP0826673B1 Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/20/2002	CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof
11/19/2002	US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002	US6482947 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners
11/19/2002	US6482859 Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives
11/19/2002	US6482836 CRF antagonistic quino- and quinazolines
11/19/2002	US6482828 4-(4′-hydroxyphenyl) amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer
11/19/2002	US6482479 Active matrix displays having high contrast values
11/19/2002	CA2080097C Process for the preparation of substituted n-(aryl)-1,2,4-triazolopyrimidine-2- sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090338A1 Method for the production of 1-amino-3-phenyl-uracil derivatives
11/14/2002	WO2002090337A1 Sulfonamides
11/14/2002	WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090314A1 Pyruvate derivatives
11/14/2002	WO2002062324A3 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/14/2002	WO2002057239A3 Pyrimidine phosphorylase as a target for imaging and therapy
11/14/2002	WO2002038534A3 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
11/14/2002	US20020169318 Novel thrombin inhibitors
11/14/2002	US20020169180 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
11/14/2002	US20020169175 4-oxo-3,4-dihydroquinazoline or 4-oxo-pyrimidine derivatives; salt formation
11/14/2002	US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002	US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002	DE10122235A1 Verfahren zur Herstellung von 1-Amino-3-phenyl-uracil-Derivaten A process for preparing 1-amino-3-phenyl-uracil derivatives
11/14/2002	CA2446120A1 Novel arylheteroalkylamine derivatives
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1256344A1 Remedies for endothelin-induced diseases
11/13/2002	EP1255755A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP1068199B1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/12/2002	US6479673 Antiretroviral enantiomeric nucleotide analogs
11/12/2002	US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479550 α-sulfenimino acid derivatives
11/12/2002	US6479500 Alleviating side effects caused by use of an anti-tumor agent comprising administering 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidin edione
11/12/2002	US6479499 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions
11/12/2002	US6479498 Comprise 2-10 sodium channel ligands covalently connected by a linker or linkers
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479485 Benzamidine derivatives and their use as anti-coagulants
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002	US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/12/2002	CA2092435C Uracil reductase inactivators
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002087587A2 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2002056827A3 Substituted felbamate derived compounds
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	WO2001034586A3 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
11/07/2002	US20020165398 Amino-thiophene-amido derivatives
11/07/2002	US20020165365 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
11/07/2002	US20020165240 Method of treating proliferative diseases using Eg5 inhibitors
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents

1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 427